KT
Kim R Tsuchimoto
Director

Kim R Tsuchimoto insider trades: Monopar Therapeutics (MNPR) stock buys and sales

Director, Monopar Therapeutics Last trade Nov 4, 2026 41 Form 4 filings
$1.2M
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2012
5
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kim reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 4, 2026MNPR↓ Sell$290K
Aug 26, 2026MNPR↓ Sell$456K
Aug 26, 2026MNPR↓ Sell$456K
Jul 14, 2025MNPR↓ Sell$356K
Dec 18, 2019MNPR↑ Buy$3K
Aug 29, 2012RPTP↓ Sell$18K
Aug 27, 2012RPTP↓ Sell$245
Jun 15, 2012RPTP↓ Sell$21K
Apr 16, 2012RPTP↓ Sell$22K
Feb 15, 2012RPTP↓ Sell$28K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MNPR insiders

Open-market trades in the last 12 months

About Kim R Tsuchimoto's insider trades

Kim R Tsuchimoto is a director at Monopar Therapeutics (MNPR). Since Feb 15, 2012, Kim has reported 1 open-market purchase worth $3K and 9 sales worth $1.6M on SEC Form 4. In the last 12 months: 3 sales ($1.2M).

Their filings also include option exercises (24 filings), grants and awards (15 filings), shares withheld for taxes (15 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MNPR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.